Hanfang Materia Medica: The dual layout of domestic and overseas industrial lines forms a synergy effect and realizes enterprise value!

This exhibitor interview directory invites Gu Xiaochun, chairman of Shenzhen Hanfang Bencao Biomedical Technology Co., Ltd., to share the global business layout of its company.

Kampo Materia Medica

Shenzhen Hanfang Materia Medica Biomedical Technology Co., Ltd. is an industrial and trade enterprise focusing on the research and development, production, sales and service of electronic atomization products. Founded in May 2020 with a registered capital of 53 million yuan, the company gives full play to the advantages of resources, policies and supply chains in multiple regions, and has now formed a multinational group operation system with Shenzhen as the headquarters and multi-regional and multi-subsidiary development in Dongguan, Hong Kong, Laos and other parts of China. The company has nearly 8,000 square meters of modern production workshop, created a 4,000 square meters of GMP standard workshop, professional sterilization room, has a number of patents, pharmacy postdoctoral and other high-end talents jointly cast a strong R & D strength. In the process of development, the company unites the upstream and downstream excellent enterprises in the industrial chain, continuously optimizes product design and production process, and has outstanding advantages in the quality and supply stability of raw materials, its own perfume and granulation capabilities, the uniqueness and innovation of products, product quality and customer experience, production efficiency and cost. The company also has the research and development and production capacity of liquid atomized electronic cigarettes and heated non-combustible smoke bombs and heaters, and has industry-leading production capacity and per capita efficiency in the field of electronic atomization through self-developed equipment and scientific supporting construction. Among them, the monthly production capacity of heating non-combustible smoke bombs is 1 million. The company adheres to the three product directions of anti-addiction and harm reduction, health gain and quality of life, adheres to the development concept of "user-oriented and technology-led enterprise", and provides outstanding product and service experience for consumers at home and abroad.

Opportunity to enter the Southeast Asian market

Kampo Materia Medica plans to enter the Southeast Asian market from 2022. Southeast Asia is an emerging market with a population base of 600 million people, with a better policy environment and industrial development environment, an open attitude towards electronic atomization, a huge market space, Euromonitor data shows that the electronic atomization market is expected to reach 766 million US dollars in 2023. Indonesia, for example, is one of the largest concentrations of electronic atomization in Southeast Asia, home to more than 200 producers and traders of new tobacco products. In addition, Southeast Asia has geographical and geographical advantages, in the geographical border with China, geographically very close to China's culture, the world's 60 million overseas Chinese in Southeast Asia accounted for 70%-75%, the effect of the Belt and Road is obvious, land, sea, air transport and various logistics channels are very perfect, to provide convenience for trade and business development. It is believed that with the excellent products of Kampo Materia Medica and an open cooperation mentality, it will quickly open up the market in Southeast Asia.

Southeast Asia market planning

In the Southeast Asian market, Kampo Materia Medica will simultaneously exert efforts from online and offline channels, build distribution channels and agent systems in the local area, actively carry out brand building and product promotion, and enter the Southeast Asian market with a diversified product matrix of electronic atomization and heating non-combustible products. The Southeast Asian market is a large area for traditional tobacco sales, but the current penetration of heat-not-burn products is still at a very low level, but Kuala Lumpur, Manila and other markets on the positive feedback of HNB products, as long as there is a cost-effective and excellent sensory experience of the product appears, will be able to promote the rapid development of the local HNB market. Kampo Materia Medica has officially produced mass production in Laos, and the Indonesian plant is also under construction and will soon be put into operation, and Kampo Materia Medica will truly build a strong supply system of heat-not-burn products by the end of this year.

Reasons to attend IECIE Jakarta Indonesia

IECIE has mature experience in exhibition organization, and this exhibition held in Indonesia, an electronic atomization center, I believe it will still be a good bridge between exhibitors and customers. Kampo Materia Medica also hopes to deeply understand the electronic atomization market and user needs in Southeast Asia through this exhibition, contact overseas customers in related fields, and reach cooperation.

Future global layout

Hanfang Materia Medica will spare no effort to focus on the electronic atomization industry, make full use of the industrial advantages of Shenzhen's world "fog capital", mainly in the territory of electronic atomization production, foundry and brand operation, overseas heating non-combustion product equipment, production capacity as the basis for cooperation, unite excellent enterprises in the industry, form a synergy effect, and then realize the integration of industrial resources and realize corporate value. From the perspective of spatial layout, the Shenzhen headquarters will be used as the investment and operation center of the group, and the Laos, Indonesia, and U.S. and Canadian subsidiaries will be used as bases to radiate business in East Asia, Southeast Asia, Europe, the United States and the Middle East.